MEDICMedicon Hellas S.A.
2.540EUR0.00%Mkt Cap: 11.23M EURP/E: 14.85Last update: 2026-05-14

Medicon Hellas S.A. operates in the diagnostics industry that offers instruments, tests, and procedures to clinical and research labs in Greece and internationally. It manufactures, imports, and provides diagnostic and p…

loading…
Indicators:|

Key Statistics

Valuation
P/E (Trailing)14.85
P/E (Forward)
PEG
P/B0.59
P/S0.61
EV/EBITDA3.45
EV/Revenue0.64
EPS (TTM)0.17
EPS (Forward)
Cash Flow & Leverage
FCF Yield3.25%
FCF Margin1.97%
Operating CF1.16M EUR
CapEx (TTM)
Net Debt/EBITDA0.12
Net Debt401.44K EUR
Technical
SMA 502.464 (+3.1%)
SMA 2002.536 (+0.2%)
Beta0.45
S&P 52W Chg24.23%
Avg Vol (30d)3.06K
Avg Vol (10d)4.81K
Technical Indicators
RSI (14)56.0
MACD0.0208
MACD Signal0.0161
MACD Hist.+0.0047
BB Upper2.592 EUR
BB Middle2.494 EUR
BB Lower2.395 EUR
BB Width7.88%
ATR (14)0.0612 EUR
Vol Ratio (20d)1.12x
52W Range
2.12052% of range2.920
52W High2.920 EUR
52W Low2.120 EUR
Profitability
Gross Margin70.43%
EBITDA Margin18.57%
Profit Margin10.23%
Oper. Margin10.21%
ROE9.63%
ROA4.31%
Revenue Growth4.90%
Earnings Growth202.20%
Balance Sheet
Debt/Equity48.61
Current Ratio5.75
Quick Ratio4.97
Book Value/Sh4.323 EUR
Cash/Share2.039 EUR
Dividends
Fwd Div Rate0.1300 EUR
Trail. Div Rate0.1300 EUR
Div. Yield5.12%
5Y Avg Yield8.00%
Payout Ratio
Ex-Div DateJul 7, 2025
Pay DateJul 11, 2001
Splits
Last Split22.03045:21.03045
Split DateMar 4, 2015
Ownership
Shares Out.4.42M
Float
Insiders44.74%
Institutions0.00%
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Company
Market Cap11.23M EUR
Enterprise Value11.89M EUR
Revenue (TTM)18.54M EUR
Gross Profit13.06M EUR
Net Income (TTM)1.86M EUR
Revenue/Share4.195 EUR
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees151
Last Price2.540 EUR
CountryGR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN